Valuation: Repligen Corporation

Market Cap 8.1B 7.04B 6.54B 6.03B 11.36B 774B 11.56B 77.39B 30.3B 384B 30.43B 29.77B 1,292B P/E 2026 *
188x
P/E 2027 * 81.5x
Enterprise Value 7.9B 6.87B 6.38B 5.88B 11.08B 755B 11.28B 75.48B 29.55B 375B 29.68B 29.03B 1,260B EV / Sales 2026 *
9.56x
EV / Sales 2027 * 7.97x
Free-Float
94.25%
Yield 2026 *
-
Yield 2027 * -
1 day+1.68%
1 week+4.36%
Current month+5.25%
1 month+5.25%
3 months+21.38%
6 months-3.86%
Current year-12.36%
1 week 130.03
Extreme 130.03
154
1 month 129
Extreme 129
154
Current year 100.99
Extreme 100.99
175.77
1 year 100.99
Extreme 100.99
175.77
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 31/08/2024
Director of Finance/CFO 52 24/09/2023
Chief Tech/Sci/R&D Officer - 31/07/2025
Director TitleAgeSince
Chairman 74 13/12/2011
Director/Board Member 60 11/06/2014
Director/Board Member 67 30/09/2015
Date Insider Type Main position Quantity % Market Cap.
16/07/26 Sell

Chief Financial Officer

-530 0.0009%
25/06/26 Sell

Chief Financial Officer

-733 0.0013%
14/05/26 Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+1.68%+4.36%+16.89%-17.58% 8.1B
-2.21%+4.82%-17.85%-6.32% 183B
-2.09%+4.51%-6.47%-2.88% 110B
-2.00%+2.35%+7.00%+67.36% 60.75B
+3.50%+0.47%+28.65%+49.27% 50.01B
-1.75%+8.16%-8.86%-40.98% 45.59B
-2.40%+3.96% - - 33.08B
-0.80%+5.76%-16.30%-43.69% 28.76B
+0.63%-4.47%+36.27%-7.08% 23.9B
-1.54%+9.77%+0.85%+0.51% 22.53B
Average -0.13%+4.53%+4.46%-0.15% 56.52B
Weighted average by Cap. -0.43%+5.49%-3.69%+3.12%

Financials

2026 *2027 *
Net sales 827M 718M 667M 615M 1.16B 78.95B 1.18B 7.9B 3.09B 39.21B 3.11B 3.04B 132B 969M 842M 782M 721M 1.36B 92.52B 1.38B 9.25B 3.62B 45.95B 3.64B 3.56B 155B
Net income 43.07M 37.41M 34.74M 32.04M 60.35M 4.11B 61.45M 411M 161M 2.04B 162M 158M 6.87B 101M 87.85M 81.58M 75.24M 142M 9.66B 144M 966M 378M 4.8B 380M 372M 16.13B
Net Debt -199M -173M -161M -148M -280M -19.04B -285M -1.9B -746M -9.46B -749M -733M -31.81B -384M -333M -309M -285M -537M -36.61B -547M -3.66B -1.43B -18.18B -1.44B -1.41B -61.15B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
30/07/26 US$143.60 +1.68% 1,042,805
29/07/26 US$141.23 -2.83% 1,514,030
28/07/26 US$145.34 +10.90% 2,508,130
27/07/26 US$131.06 -0.68% 1,456,917
24/07/26 US$131.96 -4.10% 1,359,904
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
143.60USD
Average target price
185.47USD
Spread / Average Target
+29.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock